1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Macias, M.J. Gervais, V. Civera, C. Oschkinat, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 7 375 10.1038/75144 10802733 Structural Analysis of Ww Domains and Design of a Ww Prototype 2000 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 3256.645 HYPOTHETICAL PROTEIN DOMAIN 1 man polymer no no PGWEIIHENGRPLYYNAEQKTKLHYPP PGWEIIHENGRPLYYNAEQKTKLHYPP A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n sample 4932 SACCHAROMYCES CEREVISIAE 562 ESCHERICHIA COLI repository Initial release Version format compliance Version format compliance 1 0 2000-06-02 1 1 2011-05-08 1 2 2011-07-13 PROTOTYPE WW DOMAIN FBP28WW DOMAIN FROM MUS MUSCULUS NMR RESTRAINTS FOR ENTRY 1E0N PDBE Y PDBE 2000-04-01 REL THE STRUCTURE WAS DETERMINED USING HOMONUCLEAR NMR LOWEST ENERGY 20 10 NOESY TOCSY 6.5 pH 285 K simulated annealing 1 1. NILGES, M. refinement ARIA/CNS structure solution XEASY/ARIA/CNS 600 Bruker DRX PRO 7 n 1 PRO 7 A GLY 8 n 2 GLY 8 A TRP 9 n 3 TRP 9 A GLU 10 n 4 GLU 10 A ILE 11 n 5 ILE 11 A ILE 12 n 6 ILE 12 A HIS 13 n 7 HIS 13 A GLU 14 n 8 GLU 14 A ASN 15 n 9 ASN 15 A GLY 16 n 10 GLY 16 A ARG 17 n 11 ARG 17 A PRO 18 n 12 PRO 18 A LEU 19 n 13 LEU 19 A TYR 20 n 14 TYR 20 A TYR 21 n 15 TYR 21 A ASN 22 n 16 ASN 22 A ALA 23 n 17 ALA 23 A GLU 24 n 18 GLU 24 A GLN 25 n 19 GLN 25 A LYS 26 n 20 LYS 26 A THR 27 n 21 THR 27 A LYS 28 n 22 LYS 28 A LEU 29 n 23 LEU 29 A HIS 30 n 24 HIS 30 A TYR 31 n 25 TYR 31 A PRO 32 n 26 PRO 32 A PRO 33 n 27 PRO 33 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 12 A N ILE 6 A O LEU 19 A O LEU 13 A N ASN 22 A N ASN 16 A O THR 27 A O THR 21 1 A GLU 10 -142.28 -152.40 1 A GLU 14 -96.67 -68.03 1 A ASN 22 -172.36 119.45 1 A LEU 29 -177.66 -173.94 2 A GLU 10 -138.20 -157.62 2 A ASN 15 -164.80 -4.76 2 A ASN 22 -175.34 123.75 3 A GLU 10 -135.04 -157.08 3 A ASN 15 -155.92 3.18 3 A PRO 18 -62.12 90.85 3 A LEU 29 176.57 -176.43 3 A TYR 31 -171.02 147.32 4 A GLU 10 -153.35 -156.09 4 A ASN 15 -155.86 7.75 4 A ASN 22 -172.08 130.40 4 A LYS 26 75.88 82.50 4 A PRO 32 -47.91 166.73 5 A ASN 15 -156.54 -51.42 5 A PRO 18 -32.20 138.65 5 A ASN 22 -173.51 119.40 5 A PRO 32 -49.13 168.90 6 A GLU 10 -145.84 -155.84 6 A ILE 12 -136.44 -156.40 6 A ASN 15 -165.98 27.46 6 A ASN 22 -172.78 124.28 7 A GLU 10 -136.35 -154.38 7 A PRO 18 -63.94 96.32 7 A ASN 22 -177.36 120.01 7 A LEU 29 178.37 -170.40 7 A HIS 30 -126.54 -51.57 8 A GLU 10 -137.82 -159.45 8 A ASN 15 -166.36 -11.66 8 A PRO 18 -65.18 90.31 8 A ASN 22 -172.58 126.64 8 A LYS 26 59.80 71.31 8 A LEU 29 -175.86 -171.99 9 A GLU 10 -138.06 -159.71 9 A GLU 14 -123.55 -57.11 9 A PRO 18 -66.83 93.98 9 A ASN 22 -175.25 120.52 9 A LEU 29 -178.78 -167.79 9 A HIS 30 -133.04 -50.86 10 A GLU 10 -134.95 -152.55 10 A ASN 15 -165.42 7.60 10 A PRO 18 -66.01 98.56 10 A ASN 22 -175.17 120.62 10 A LEU 29 179.26 171.12 HYPOTHETICAL PROTEIN YJQ8WW domain from Saccharomyces cerevisae 1 N N YJQ8WW DOMAIN YJQ8WW DOMAIN, WW DOMAIN, SACCHAROMYCES CEREVISAE, YJQ8 PROTEIN A PRO 32 A PRO 26 7 A PRO 33 A PRO 27 1.86 A TYR 31 A TYR 25 9 A PRO 32 A PRO 26 -1.85 A TYR 31 A TYR 25 10 A PRO 32 A PRO 26 -3.11 1E0N PDB 1 1E0N 7 33 1E0N 7 33 1E0N A 1 1 27 3 anti-parallel anti-parallel A TRP 9 A TRP 3 A GLU 14 A GLU 8 A ARG 17 A ARG 11 A ALA 23 A ALA 17 A LYS 26 A LYS 20 A HIS 30 A HIS 24 1 P 1